Kyle Faget Discusses Regulating Software as a Medical Device on MedTech Connect Podcast
06 January 2023
Foley & Lardner LLP Partner Kyle Faget is interviewed in the first episode of MedTech Connect, a new digital health podcast series by Medtech Insight, about the complexities behind regulating software as a medical device (SaMD).
In the episode, “How Do We Regulate Software as a Medical Device?” Faget offers valuable insight on the regulatory landscape of SaMD, and provides clarity for businesses that might be unsure if their software is even regulated by the U.S. Food and Drug Administration, let alone understand how to go about the clearance process.
Listen to the episode on Apple Podcasts, SoundCloud, and Spotify.
(Subscription required)
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”